Alzheimer's disease (AD) is the most common type of dementia. In 2019, total expenses for providing long-term and hospice care for people aged ≥ 65 years with dementia and AD were estimated to be almost $290 billion worldwide. From 2000 to 2017, total deaths due to CVA, heart disease, and prostate cancer diminished, while reported deaths due to AD significantly increased by 145%. In 2018, almost 16 million family members and other voluntary caregivers provided 18.5 billion hours of care to individuals with AD or dementia (
1). The disease not only has a significant impact on the patient and his/her family’s quality of life but also has high social and economic costs (
2). The total annual budgets are estimated at $507.49 billion in 2030 and $1.89 trillion in 2050 (
3). According to studies, an increase of more than 300% will be seen in India, China, and other South Asian countries, about 70% of which are attributed to AD. In Iran, it is predicted that by the next three decades, 25% of the population will become old, and eight to 10% will suffer from AD (
4).
The main features of AD are familial and idiopathic. In the family type, which accounts for approximately 5% of the cases, AD begins before 65, while the idiopathic type accounts for 95% of the cases and is associated with aging and some identified risk factors (
4). Cerebrovascular disease, diabetes, hypertension, obesity, and hyperlipidemia are most important among modifiable factors (
5). Some comprehensive studies identified other factors, including smoking, depression, mental inactivity, physical inactivity, poor diet, and low education level (
6). It is estimated that one-third of AD cases are related to these factors and thus preventable (
7).
The eight important modifiable risk factors include low cognitive reserve, tobacco use, sedentary lifestyle, obesity, hypertension in middle age, and diabetes, in sequence, and each factor accounts for between 2% and 20% of AD risk (
8). Ennis et al. (2017), in a 10-year longitudinal study, observed the increased cortisol levels in 1,025 participants in 24-h urine samples (
9). Also, smoking by stimulating pro-inflammatory action in the immune system is associated with an increased risk of AD (
10). Controversially, protective factors like cognitive reserve, physical activity, and estrogen are associated with reduced AD risk (
11).
A better understanding of the triggering or protective factors involved in initiating/progressing or delaying/suppressing AD seems essential to promote and develop new interventions and treatments (
12). Preventive strategies by delaying the onset of AD can reduce the global economic burden and social impacts of the disease (
13). Accurate control of AD risk factors plays a major role in advancing these mitigating and preventive strategies (
14).
The pathogenesis of AD, besides genetic and societal factors, is the consequence of various environmental factors. By the growth of society, new exposure to environmental factors and their adverse effects, which may be imposed on human healthiness, is not completely recognized. It is a common matter of consensus that environmental factors may lead to AD based on hereditary predisposition (
15).
In Iran, by 2050, it is projected that around 33% of the population is over 60, which leads to an increase in AD cases and high annual costs (about $ 1,500 per person for AD) for the treatment of these patients (
16). But so far, scarce research has been conducted on AD among the elderly population of the southwest region of Iran. However, the importance of the present study and the need for a more coherent study of risk factors associated with AD seem to be increasingly essential.